Sarcopenia Risk(少肌症风险)研究综述
Sarcopenia Risk 少肌症风险 - After adjustment for confounders, PEFRs of <50% and 50% to 80% were associated with an increased sarcopenia risk (odds ratio = 5. [1] Purpose This study aimed i) to identify the best cutoff points of neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) that predict sarcopenia and ii) to illustrate the association between sarcopenia risk and NLR or PLR in renal cell carcinoma (RCC) patients undergoing laparoscopic partial or radical nephrectomy. [2] Thus, we investigated the reliability and validity of measuring temporal muscle thickness (TMT) as an indicator of sarcopenia risk and its relationship with functional outcome in older patients with acute stroke. [3] Females with higher urinary monoethyl phthalate (MEP) concentrations had higher sarcopenia risk. [4] The purpose of the study was to examine the hypothesis that polygenetic variants for sarcopenic risk had interactions with metabolic disorders and lifestyles associated with sarcopenia risk in adults >50 years in a large urban hospital cohort. [5] Thus, the present study identified whether depressive symptoms are associated with older adults’ sarcopenia risks. [6] Potentially, such a tool may be the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire, which is available in a seven-item (MSRA-7) and five-item (MSRA-5) version. [7] Sarcopenia risk factors differ among cirrhosis etiologies. [8] Prospective lifestyle approaches that target the gut-muscle axis have recently been examined in the context of mitigating sarcopenia risk. [9] Our findings highlight the need for further research on dietary protein as a potential modifying factor of sarcopenia risk in middle age. [10] Aim The aim of the study was to evaluate if the 7 items of Mini Sarcopenia Risk Assessment (MSRA) questionnaire predict muscle mass loss in a population of community-dwelling elderly subjects over a 5. [11] Meaningful results were obtained for the Mediterranean diet and Nordic diet regarding the decrease of sarcopenia risk, however results from non-European countries were inconsistent. [12] The aim of the present cross-sectional study was to determine whether or not engagement in MSA is linked to sarcopenia risk in older adults who meet the PA guidelines of 150 min of MVPA per week. [13] The aim of our prospective cohort study is to investigate the association between sarcopenia risk and severe disease among COVID-19 patients aged ≥60 years. [14] Compared strategies included Sarcopenia scoring assessment models (SarSA-Mod), European working group on sarcopenia in older people (EWGSOP), Mini sarcopenia risk assessment (MSRA) and SARC-F. [15] To evaluate sarcopenia risk in hospitalized older patients. [16] The present study was designed to identify the association between fibrinogen, fibrin degradation products (FDP) and sarcopenia risk in hospitalized old patients. [17] OBJECTIVE Rheumatoid arthritis and age are associated with high sarcopenia risk. [18] The aim of the present study was to explore the impact of adherence to healthy dietary patterns on sarcopenia risk in a sample of physically active older men and women, while considering adherence to guidelines on muscle strengthening activities (MSA) and protein intake. [19] Following adjustment for confounding variables, binary logistic regression analyses revealed that inadequate vitamin D was able to independently predict sarcopenia risk only in males (OR=1. [20] The effects of demographic characteristics, posture, level of physical activity, disc herniation type, and sarcopenia risk on the CSAs of paraspinal muscles were evaluated along with the relationship between the CSAs and severity of pain and disability in all patients. [21] However, its impact on human muscle health was not evident, suggesting that circulating CCL11 may not be a useful biomarker for sarcopenia risk assessment in older adults. [22] Preclinical and clinical studies have shown differential impacts of anti-diabetic drugs on skeletal muscle mass, strength, and performance, highlighting the importance of rational therapeutic regimen from the perspective of sarcopenia risk. [23] There is a growing evidence base that links low micronutrient intakes to sarcopenia risk and/or its components (low muscle strength and mass, impaired physical performance), although there remain many gaps in understanding. [24] , sleep duration, bedtime, wake time, or mid-sleep time) and sarcopenia risks in older adults, in the total sample and age group subsamples. [25] Background: SARC-F and Mini Sarcopenia Risk Assessment (MSRA) questionnaires have been proposed as screening tools to identify patients at risk of sarcopenia. [26]调整混杂因素后，PEFR <50% 和 50% 至 80% 与肌肉减少症风险增加相关（比值比 = 5. [1] 目的 本研究旨在 i) 确定预测肌肉减少症的中性粒细胞 - 淋巴细胞比率 (NLR) 和血小板 - 淋巴细胞比率 (PLR) 的最佳截止点，以及 ii) 说明肾细胞癌中肌肉减少症风险与 NLR 或 PLR 之间的关联。 RCC) 接受腹腔镜肾部分切除术或根治性肾切除术的患者。 [2] 因此，我们调查了测量颞肌厚度 (TMT) 作为肌肉减少症风险指标的可靠性和有效性及其与老年急性卒中患者功能结果的关系。 [3] 尿中邻苯二甲酸单乙酯 (MEP) 浓度较高的女性具有较高的肌肉减少症风险。 [4] 该研究的目的是检验一个假设，即在大型城市医院队列中，50 岁以上成人的肌肉减少症风险的多基因变异与代谢紊乱和与肌肉减少症风险相关的生活方式存在相互作用。 [5] 因此，本研究确定了抑郁症状是否与老年人的肌肉减少症风险相关。 [6] 这种工具可能是小型肌肉减少症风险评估 (MSRA) 问卷，有七项 (MSRA-7) 和五项 (MSRA-5) 版本。 [7] 不同肝硬化病因的肌肉减少症风险因素不同。 [8] 最近在减轻肌肉减少症风险的背景下研究了针对肠道肌肉轴的前瞻性生活方式方法。 [9] 我们的研究结果强调需要进一步研究膳食蛋白质作为中年肌肉减少症风险的潜在调节因素。 [10] 目的 本研究的目的是评估 7 项小型肌肉减少症风险评估 (MSRA) 问卷是否可以预测社区居住的 5 岁以上老年人群的肌肉质量损失。 [11] 地中海饮食和北欧饮食在减少肌肉减少症风险方面取得了有意义的结果，但来自非欧洲国家的结果并不一致。 [12] 本横断面研究的目的是确定参与 MSA 是否与符合每周 150 分钟 MVPA 的 PA 指南的老年人的肌肉减少症风险有关。 [13] 我们前瞻性队列研究的目的是调查年龄≥60 岁的 COVID-19 患者的肌肉减少症风险与严重疾病之间的关联。 [14] 比较策略包括肌肉减少症评分评估模型 (SarSA-Mod)、欧洲老年人肌肉减少症工作组 (EWGSOP)、小型肌肉减少症风险评估 (MSRA) 和 SARC-F。 [15] 评估住院老年患者的肌肉减少症风险。 [16] 本研究旨在确定住院老年患者的纤维蛋白原、纤维蛋白降解产物 (FDP) 和肌肉减少症风险之间的关联。 [17] 客观的 类风湿性关节炎和年龄与高肌肉减少症风险相关。 [18] 本研究的目的是探讨坚持健康饮食模式对身体活跃的老年男性和女性样本中肌肉减少症风险的影响，同时考虑遵守肌肉强化活动 (MSA) 和蛋白质摄入指南。 [19] 在调整混杂变量后，二元逻辑回归分析显示，维生素 D 不足仅能独立预测男性的肌肉减少症风险（OR=1. [20] 评估人口统计学特征、姿势、体力活动水平、椎间盘突出类型和肌肉减少症风险对所有患者的椎旁肌 CSA 的影响，以及 CSA 与疼痛和残疾严重程度之间的关系。 [21] 然而，它对人体肌肉健康的影响并不明显，这表明循环 CCL11 可能不是老年人肌肉减少症风险评估的有用生物标志物。 [22] 临床前和临床研究表明，抗糖尿病药物对骨骼肌质量、力量和性能的不同影响，从肌肉减少症风险的角度突出了合理治疗方案的重要性。 [23] 越来越多的证据表明，微量营养素摄入量低与肌肉减少症风险和/或其组成部分（肌肉力量和质量低，身体机能受损）有关，尽管在理解上仍存在许多差距。 [24] 、睡眠时间、就寝时间、起床时间或睡眠中期时间）和老年人的肌肉减少症风险，在总样本和年龄组子样本中。 [25] 背景：已提出 SARC-F 和小型肌肉减少症风险评估 (MSRA) 问卷作为筛查工具，以识别有肌肉减少症风险的患者。 [26]
Mini Sarcopenia Risk
Potentially, such a tool may be the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire, which is available in a seven-item (MSRA-7) and five-item (MSRA-5) version. [1] Aim The aim of the study was to evaluate if the 7 items of Mini Sarcopenia Risk Assessment (MSRA) questionnaire predict muscle mass loss in a population of community-dwelling elderly subjects over a 5. [2] Compared strategies included Sarcopenia scoring assessment models (SarSA-Mod), European working group on sarcopenia in older people (EWGSOP), Mini sarcopenia risk assessment (MSRA) and SARC-F. [3] Background: SARC-F and Mini Sarcopenia Risk Assessment (MSRA) questionnaires have been proposed as screening tools to identify patients at risk of sarcopenia. [4]这种工具可能是小型肌肉减少症风险评估 (MSRA) 问卷，有七项 (MSRA-7) 和五项 (MSRA-5) 版本。 [1] 目的 本研究的目的是评估 7 项小型肌肉减少症风险评估 (MSRA) 问卷是否可以预测社区居住的 5 岁以上老年人群的肌肉质量损失。 [2] 比较策略包括肌肉减少症评分评估模型 (SarSA-Mod)、欧洲老年人肌肉减少症工作组 (EWGSOP)、小型肌肉减少症风险评估 (MSRA) 和 SARC-F。 [3] 背景：已提出 SARC-F 和小型肌肉减少症风险评估 (MSRA) 问卷作为筛查工具，以识别有肌肉减少症风险的患者。 [4]
sarcopenia risk assessment
Potentially, such a tool may be the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire, which is available in a seven-item (MSRA-7) and five-item (MSRA-5) version. [1] Aim The aim of the study was to evaluate if the 7 items of Mini Sarcopenia Risk Assessment (MSRA) questionnaire predict muscle mass loss in a population of community-dwelling elderly subjects over a 5. [2] Compared strategies included Sarcopenia scoring assessment models (SarSA-Mod), European working group on sarcopenia in older people (EWGSOP), Mini sarcopenia risk assessment (MSRA) and SARC-F. [3] However, its impact on human muscle health was not evident, suggesting that circulating CCL11 may not be a useful biomarker for sarcopenia risk assessment in older adults. [4] Background: SARC-F and Mini Sarcopenia Risk Assessment (MSRA) questionnaires have been proposed as screening tools to identify patients at risk of sarcopenia. [5]这种工具可能是小型肌肉减少症风险评估 (MSRA) 问卷，有七项 (MSRA-7) 和五项 (MSRA-5) 版本。 [1] 目的 本研究的目的是评估 7 项小型肌肉减少症风险评估 (MSRA) 问卷是否可以预测社区居住的 5 岁以上老年人群的肌肉质量损失。 [2] 比较策略包括肌肉减少症评分评估模型 (SarSA-Mod)、欧洲老年人肌肉减少症工作组 (EWGSOP)、小型肌肉减少症风险评估 (MSRA) 和 SARC-F。 [3] 然而，它对人体肌肉健康的影响并不明显，这表明循环 CCL11 可能不是老年人肌肉减少症风险评估的有用生物标志物。 [4] 背景：已提出 SARC-F 和小型肌肉减少症风险评估 (MSRA) 问卷作为筛查工具，以识别有肌肉减少症风险的患者。 [5]